AAAAAA

   
Results: 1-25 | 26-47 |
Results: 26-47/47
Antibiotic therapy for infections in the head and neck
Authors: Federspil, P Elies, W Luckhaupt, H Marklein, G Mollenhauer, HW Otten, JE Otto, K Pelz, K Scholz, H Schrappe, M",Seifert,"Staib, AH Straube, E Sybrecht, GW Unertl, K Federspil, A
Citation: P. Federspil et al., Antibiotic therapy for infections in the head and neck, HNO, 48(2), 2000, pp. 91-103
Quality assurance in head and neck surgical oncology: results of a German nationwide survey
Authors: Eckel, HE Streppel, M Schmalenbach, K Volling, P Schrappe, M Dietz, A Bootz, F
Citation: He. Eckel et al., Quality assurance in head and neck surgical oncology: results of a German nationwide survey, HNO, 48(12), 2000, pp. 902-910
Do guidelines bring an improvement in the perioperative course? - An investigation of perioperative antibiotic prophylaxis
Authors: Wolters, U Schrappe, M Mohrs, D Bollschweiler, E Holscher, AH
Citation: U. Wolters et al., Do guidelines bring an improvement in the perioperative course? - An investigation of perioperative antibiotic prophylaxis, CHIRURG, 71(6), 2000, pp. 702-706
Pegylated asparaginase (Oncaspar (TM)) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols
Authors: Muller, HJ Loning, L Horn, A Schwabe, D Gunkel, M Schrappe, M von Schutz, V Henze, G da Palma, JC Ritter, J Pinheiro, JPV Winkelhorst, M Boos, J
Citation: Hj. Muller et al., Pegylated asparaginase (Oncaspar (TM)) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols, BR J HAEM, 110(2), 2000, pp. 379-384
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to inductionchemotherapy and relapse rate in childhood acute lymphoblastic leukaemia
Authors: Wuchter, C Karawajew, L Ruppert, V Schrappe, M Harbott, J Ratei, R Dorken, B Ludwig, WD
Citation: C. Wuchter et al., Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to inductionchemotherapy and relapse rate in childhood acute lymphoblastic leukaemia, BR J HAEM, 110(1), 2000, pp. 154-160
No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence
Authors: Stanulla, M Stumm, M Dieckvoss, BO Seidemann, K Schemmel, V Brechlin, AM Schrappe, M Welte, K Reiter, A
Citation: M. Stanulla et al., No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence, BR J HAEM, 109(1), 2000, pp. 117-120
Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with Bcl-2up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia
Authors: Karawajew, L Ruppert, V Wuchter, C Kosser, A Schrappe, M Dorken, B Ludwig, WD
Citation: L. Karawajew et al., Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with Bcl-2up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia, BLOOD, 96(1), 2000, pp. 297-306
Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy
Authors: Loning, L Zimmermann, M Reiter, A Kaatsch, P Henze, G Riehm, H Schrappe, M
Citation: L. Loning et al., Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy, BLOOD, 95(9), 2000, pp. 2770-2775
Early response in infant ALL determines prognosis
Authors: Dordelmann, M Schrappe, M
Citation: M. Dordelmann et M. Schrappe, Early response in infant ALL determines prognosis, BLOOD, 95(8), 2000, pp. 2730-2731
Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1)and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study
Authors: Stanulla, M Schrappe, M Brechlin, AM Zimmermann, M Welte, K
Citation: M. Stanulla et al., Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1)and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study, BLOOD, 95(4), 2000, pp. 1222-1228
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Groupreport
Authors: Reiter, A Schrappe, M Ludwig, WD Tiemann, M Parwaresch, R Zimmermann, M Schirg, E Henze, G Schellong, G Gadner, H Riehm, H
Citation: A. Reiter et al., Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Groupreport, BLOOD, 95(2), 2000, pp. 416-421
Improved outcome in childhood acute lymphoblastic leukemia despite reduceduse of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90
Authors: Schrappe, M Reiter, A Ludwig, WD Harbott, J Zimmermann, M Hiddemann, W Niemeyer, C Henze, G Feldges, A Zintl, F Kornhuber, B Ritter, J Welte, K Gadner, H Riehm, H
Citation: M. Schrappe et al., Improved outcome in childhood acute lymphoblastic leukemia despite reduceduse of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90, BLOOD, 95(11), 2000, pp. 3310-3322
A prospective evaluation of the cost effectiveness of adding lamivudine tozidovudine-containing antiretroviral treatment regimens in HIV infection -European perspective
Authors: Lacey, L Youle, M Trueman, P Staszewski, S Schrappe, M Behrens, M
Citation: L. Lacey et al., A prospective evaluation of the cost effectiveness of adding lamivudine tozidovudine-containing antiretroviral treatment regimens in HIV infection -European perspective, PHARMACOECO, 15, 1999, pp. 39-53
A powerful DNA extraction method and PCR for detection of microsporidia inclinical stool specimens
Authors: Muller, A Stellermann, K Hartmann, P Schrappe, M Fatkenheuer, G Salzberger, B Diehl, V Franzen, C
Citation: A. Muller et al., A powerful DNA extraction method and PCR for detection of microsporidia inclinical stool specimens, CL DIAG LAB, 6(2), 1999, pp. 243-246
Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia
Authors: Takeuchi, S Cho, SK Seriu, T Koike, M Bartram, CR Reiter, A Schrappe, M Takeuchi, C Taguchi, H Koeffler, HP
Citation: S. Takeuchi et al., Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia, ONCOGENE, 18(51), 1999, pp. 7387-7388
Antiinfectious prophylaxis in pediatric oncology
Authors: Graubner, UB Boos, J Creutzig, U Dorffel, W Lakomek, M Niemeyer, C Schrappe, M Spaar, HJ Belohradsky, BH
Citation: Ub. Graubner et al., Antiinfectious prophylaxis in pediatric oncology, KLIN PADIAT, 211(4), 1999, pp. 347-352
Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection
Authors: Cornely, OA Hauschild, S Weise, C Csernok, E Gross, WL Salzberger, B Fatkenheuer, G Diehl, V Schrappe, M
Citation: Oa. Cornely et al., Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection, INFECTION, 27(2), 1999, pp. 92-96
Secondary brain tumours in children with ALL
Authors: Stanulla, M Loning, L Welte, K Schrappe, M
Citation: M. Stanulla et al., Secondary brain tumours in children with ALL, LANCET, 354(9184), 1999, pp. 1126-1127
Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols
Authors: Pinheiro, JPV Ahlke, E Nowak-Gottl, U Hempel, G Muller, HJ Lumkemann, K Schrappe, M Rath, B Fleischhack, G Mann, C Boos, J
Citation: Jpv. Pinheiro et al., Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols, BR J HAEM, 104(2), 1999, pp. 313-320
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia
Authors: Dordelmann, M Reiter, A Borkhardt, A Ludwig, WD Gotz, N Viehmann, S Gadner, H Riehm, H Schrappe, M
Citation: M. Dordelmann et al., Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia, BLOOD, 94(4), 1999, pp. 1209-1217
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: Results of Dutch Childhood Leukemia Study Group protocol ALL-7 (1988-1991)
Authors: Kamps, WA Bokkerink, JPM Hahlen, K Hermans, J Riehm, H Gadner, H Schrappe, M Slater, R van den Berg-de Ruiter, E Smets, LA de Vaan, GAM Weening, RS van Weerden, JF van Wering, ER van der Does-van den Berg, A
Citation: Wa. Kamps et al., Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: Results of Dutch Childhood Leukemia Study Group protocol ALL-7 (1988-1991), BLOOD, 94(4), 1999, pp. 1226-1236
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster group trial NHL-BFM 90
Authors: Reiter, A Schrappe, M Tiemann, M Ludwig, WD Yakisan, E Zimmermann, M Mann, G Chott, A Ebell, W Klingebiel, T Graf, N Kremens, B Muller-Weihrich, S Pluss, HJ Zintl, F Henze, G Riehm, H
Citation: A. Reiter et al., Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster group trial NHL-BFM 90, BLOOD, 94(10), 1999, pp. 3294-3306
Risultati: 1-25 | 26-47 |